Biond Biologics Appoints Jerome Zeldis, M.D., Ph.D., Former Chief Medical Officer of Celgene, to Board of Directors and Provides Corporate Update

    NEXT STORY
    Ayala Pharmaceuticals to Present at Upcoming Investor Conferences
    PREV STORY
    Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome (“IBS”) Diagnostic-Guided Therapy clinical trial
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis

    author_avatar
    NASDAQ Market News

    TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week

    PRESS RELEASE TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week ...

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Appoints Thomas A. Larson as Chief Commercial Officer

    COPENHAGEN, Denmark, April 02, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical ...

    author_avatar
    NASDAQ Market News